4.7 Article

Aurintricarboxylic acid inhibits influenza virus neuraminidase

Journal

ANTIVIRAL RESEARCH
Volume 81, Issue 2, Pages 123-131

Publisher

ELSEVIER
DOI: 10.1016/j.antiviral.2008.10.006

Keywords

Aurintricarboxylic acid; Influenza; Neuraminidase; Antivirals

Funding

  1. National Health Research Institutes (NHRI)
  2. National Science Council (NSC) in Taiwan, Republic of China [NHRI-BP-097-PP-07, NSC95-2745-B-400-002]

Ask authors/readers for more resources

There is a continuing threat that the highly pathogenic avian influenza virus will cause future influenza pandemics. In this study, we screened a library of compounds that are biologically active and structurally diverse for inhibitory activity against influenza neuraminidase (NA). We found that aurintricarboxylic acid (ATA) is a potent inhibitor of NA activity of both group-1 and group-2 influenza viruses with IC50S (effective concentration to inhibit NA activity by 50%) values at low micromolar concentrations. ATA was equally potent in inhibiting the NA activity derived from wild-type NA and its H274Y mutant which renders NA resistance to inhibition by oseltamivir. Although ATA is structurally distinct from sialic acid, molecular modeling experiments suggested that ATA binds to NA at the enzyme's substrate binding site. These results indicate that ATA may be a good starting material for the design of a novel class of NA inhibitors for the treatment influenza viruses. (C) 2008 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available